Word: brutalized
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...besotted with her singing teacher, Sylvia (Jaoui) or chasing after a boy who doesn't want her. But Berry keeps her character optimistic and determined, going from lovable to intolerable and back again while she fights to find a place in her father's world. As Etienne, Bacri is brutal, callous and beyond redemption. In The Taste of Others, Bacri's lovelorn character is cranky but harmless; in Look at Me, he's pure bastard. His young wife, Karine, and his put-upon assistant, Vincent, are prime targets for his temper tantrums and cruel sarcasm, but they...
Mostly, though, it is crime—brutal, clipped, ass-kicking crime—that garners Ellroy’s attention. As the title suggests, Destination: Morgue!, like most of Ellroy’s writing, does not shrink from this dark theme. Its pages, if they emulated their contents, would be ripped, blood-soaked and stomped...
...will be remembered for the colossal misjudgments that cost him his rule. The exhaustive detail compiled by the report's author, Charles Duelfer, chief U.N. weapons inspector in the 1990s and the Bush Administration's top hunter since January, richly fills in the previous portrait of a paranoid and brutal dictator who believed that weapons of mass destruction (WMD) were the prime tools with which to advance his extravagant ambitions. Drawn from lengthy interrogations of the core Iraqi leadership and Saddam during their months in U.S. custody, the Duelfer report sheds fresh light on the dictator's inner motivations...
While hitting the Yard at 7:30 a.m. may seem brutal, veterans argue it is the only way to outwit, outlast and outplay the competition...
...reaction on Wall Street was swift and brutal. Merck's chief executive Ray Gilmartin announced that the company's 2004 earnings could shrink as much as 20%. Its stock promptly lost $28 billion of its market value, temporarily dragging the Dow Jones industrial average down with it. The timing could not have been worse for Merck, whose sales last year grew a paltry 5%, compared with 23% in 2000, and whose big anticholesterol drug Zocor will lose patent protection in 2006, with nothing to replace it. Some analysts wondered whether the company was ripe for a merger--an idea Merck...